When cancer patients encountered COVID-19: clinical characteristics and outcome in China
During the COVID-19 Omicron epidemic, there seemed to be some association between various antitumor therapies, treatment intervals, and COVID-19 severity. The findings of this study can potentially help allay cancer patients` fears regarding COVID-19 infection and enable them to continue with crucial therapeutic processes for the treatment of cancer.
Authors
- Guojing Wang
- Xi Wu (ORCID: https://orcid.org/0009-0002-5996-4624)
- Qingzhu Gao (ORCID: https://orcid.org/0000-0003-1903-7375)
- Wei Cui (ORCID: https://orcid.org/0000-0002-6602-4406)
- Wenfeng Zhang (ORCID: https://orcid.org/0000-0003-0784-5228)
- Xiaotian Xu (ORCID: https://orcid.org/0000-0003-3862-1630)
- Xueting Yu (ORCID: https://orcid.org/0000-0002-1463-7630)
- Shengkai Huang (ORCID: https://orcid.org/0000-0001-6702-243X)
- Xin Dong (ORCID: https://orcid.org/0000-0001-9898-288X)
- Baojun Wei
- Kai Guo
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3855/jidc.19965
- Primary Topic
- COVID-19 and healthcare impacts
- Type
- article
- Field-Weighted Citation Impact
- 0.00